Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Transient neonatal myasthenia gravis |
French
|
Myasthénie transitoire néonatale |
| Level | Code | Title | |
|---|---|---|---|
| 1 | XVI | Certain conditions originating in the perinatal period | |
| 2 | P90-P96 | Other disorders originating in the perinatal period | |
| 3 | P94 | Disorders of muscle tone of newborn | |
| 4 | P94.0 | Transient neonatal myasthenia gravis |
| Active Ingredient | Description | |
|---|---|---|
| Neostigmine |
Neostigmine inhibits cholinesterase activity and prolongs and intensifies the muscarinic and nicotinic effects of acetylcholine. The anticholinesterase actions of neostigmine are reversible. It is used mainly for its action on skeletal muscle and less frequently to increase the activity of smooth muscle. |
|
| Pyridostigmine |
Pyridostigmine is an antagonist to cholinesterase, the enzyme which normally destroys acetylcholine. The action of pyridostigmine can briefly be described, therefore, as the potentiation of naturally occurring acetylcholine. |
